APA (7th ed.) Citation

C, K., H, I., K, N., H, S., K, T., N, T., . . . N, B. (2025). Peripheral SNCA+ cells as a poor prognostic factor for nivolumab therapy in advanced gastric cancer. Discover oncology, 16(1), 1951. https://doi.org/10.1007/s12672-025-03817-0

Chicago Style (17th ed.) Citation

C, Kudo-Saito, et al. "Peripheral SNCA+ Cells as a Poor Prognostic Factor for Nivolumab Therapy in Advanced Gastric Cancer." Discover Oncology 16, no. 1 (2025): 1951. https://doi.org/10.1007/s12672-025-03817-0.

MLA (9th ed.) Citation

C, Kudo-Saito, et al. "Peripheral SNCA+ Cells as a Poor Prognostic Factor for Nivolumab Therapy in Advanced Gastric Cancer." Discover Oncology, vol. 16, no. 1, 2025, p. 1951, https://doi.org/10.1007/s12672-025-03817-0.